MedTrace Logo

Investigations of the Effect of MK-7 on Bone and Glucose Metabolism and Arterial Calcification

NCT01922804 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2016-10-28

No results posted yet for this study

Summary

The aims of the present study are to investigate the effect of vitamin K2 on bone turnover, bone mass, bone structure, glucose metabolism, and arteriosclerosis.

Osteoporosis, diabetes, metabolic syndrome and cardiovascular disease are common diseases that affect large groups of people in the Western world.

Our hypotheses is that vitamin K2 (MK-7) reduces undercarboxylated osteocalcin in postmenopausal women and reduces bone turnover and increases bone mineral density; increases insulin sensitivity and decreases indices of arterial calcification.

Conditions

  • Metabolic Bone Disorder

Interventions

DIETARY_SUPPLEMENT

K2 vitamin

K2 vitamin tablet

DIETARY_SUPPLEMENT

Placebo

Placebo tablets

Sponsors & Collaborators

  • Axellus

    collaborator INDUSTRY

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Sofie Rønn, cand.med · Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2017-04-30
Completion
2018-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01922804 on ClinicalTrials.gov